Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Thanarajasingam

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2022
A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus ErythematosusMelissa E Munroe, Derek Blankenship, Daniele DeFreese, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse eventsFaisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2022
A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus ErythematosusMelissa E Munroe, Derek Blankenship, Daniele DeFreese, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse eventsFaisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
Pageof 4